Swedish digital health company Coala Life has launched a virtual cardiac and respiratory diagnostics solution for the real-time, P-wave-based detection of nine common arrhythmias.
The smartphone-powered solution allows physicians to remotely detect murmurs and auscultate the heart and lungs.
The company is currently offering the configurable solution with expanded indications, including home-based enrollment capabilities, patch-free, multi-lead and high-resolution ECG analysis, as well as real-time data transmission of heart and lung sounds.
The company, in partnership with the St Louis Heart and Vascular (SLHV) Clinics, will also offer round-the-clock integrated monitoring services to support specific reimbursement requirements.
SLHV partner and cardiologist Gil Vardi said: “The transition to telemedicine and virtual diagnostics is here to stay. The Coala is a powerful tool for real-time diagnostics and ideal for patients with suspected or confirmed cardiac disease, as well as monitoring pulmonary issues such as COPD.”
Earlier this year, Coala expanded the indication of its heart monitor for use in Covid-19 respiratory diagnostic exams.
The company also noted that its Microsoft Azure-based platform is helping physicians to remotely access data to optimise the management of patients during the current pandemic.
The Covid-19 pandemic has quickly transformed cardiovascular medicine with the shift from traditional hands-on care to remote hands-off telemedicine to keep patients and their medical staff safe, it said.
Its heart monitor is also used for virtual cardiac diagnostics, longer-term chronic care programmes, rural health programmes and post-procedural monitoring.
The Coala solutions are said to be proven in clinical studies to help reduce palpitation symptoms and increase the quality of life.